Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.110
+0.030 (2.78%)
May 2, 2024, 4:00 PM EDT - Market closed
MCRB's stock price has decreased by -76.23% in the past year and price targets may not have had time to catch up.
Seres Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$6.56
Upside
+490.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +350.45% | Mar 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +620.72% | Mar 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +710.81% | Jan 16, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $1.25 | Strong Sell | Maintains | $4 → $1.25 | +12.61% | Nov 3, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $12 | Buy | Initiates | $12 | +981.08% | Jun 26, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +800.90% | Apr 28, 2023 |
| JP Morgan | JP Morgan | Hold Initiates $7 | Hold | Initiates | $7 | +530.63% | Apr 21, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $15 | Strong Buy | Maintains | $11 → $15 | +1,251.35% | Mar 21, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +890.99% | Mar 8, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +981.08% | Mar 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +2,152.25% | Mar 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +2,152.25% | Feb 8, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +710.81% | Sep 7, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $32 → $7 | Buy | Maintains | $32 → $7 | +530.63% | May 23, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 23, 2021 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Jul 23, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 5, 2021 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 5, 2021 |